Ebit تغيير تاريخ
AbbVie USD 5.81B 4.36B 2025-12
Agenus USD -13.31M 19.08M 2025-03
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Ardelyx USD 7.12M 19.62M 2025-09
aTyr Pharma USD -226.49K 140.85K 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Curis USD -12.37M 230K 2023-09
Eli Lilly USD 8.99B 1.57B 2025-12
Incyte USD 383.88M 47.44M 2025-12
MacroGenics USD 20.16M 55.51M 2025-09
Novartis USD -9.19B 13.87B 2025-06
Novartis USD 4.48B 343M 2025-09
Pfizer USD 4.65B 71M 2025-12
Prothena USD -39.76M 12.25M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Xoma USD -10.08M 4.4M 2024-06